Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.

Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Novartis works closely with healthcare professionals around the world to support ...

Documentation Specialist (f/m/d), Kundl, Tirol, Austria Befristet (Befristet), Full time Innovative Medicines Österreich Kundl Apr 10, 2025 ...

Leader mondial dans le domaine de la santé, Novartis propose actuellement l’un des portefeuilles les plus complets du marché. Un portefeuille de médicaments innovants, développés par des personnes ...

חפשו אחר אפשרויות תעסוקה בחברת נוברטיס וסנדוז. לתפקידים נוספים ב Novartis Gene Therapies (formerly AveXis) בקרו בGTx Career Search הודעה למתמודדים על משרות בארה"ב.

Job Title Sort ascending Business Location Site Date Posted Vodja skupine klinične proizvodnje (m/ž/d) / Senior Manager Clinical Manufacturing (m/f/d) Regulär, Full time Innovative Medicines Slovenia ...

诺华 承 诺 与残障人士共事并 为 他 们 提供合理的便利 设 施。如果您由于健康状况或残障 在招聘 过 程的任何 环 节 需要合理便利 设 施 或者 为 了履行 职 位的基本 职 能 请发 送 电 子 邮 件 ...

V Novartisu spodbujamo inovativnost in razvoj ter delujemo na številnih področjih. Tudi vi lahko postanete del tega, del naše zgodbe. Pridružite se naši ustvarjalni skupnosti strokovnjakov in našli ...

Job Title Sort ascending Business Location Site Date Posted Medical Affairs Lead Regolare, Full time Germany +Alternative Locations Munich (Non-Sales Force) (Novartis Pharma GmbH) Apr 11, 2025 ...

Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...

Senior Expert en Transfert et Validation Analytique (H/F) - CDD CDD (durée déterminée), Full time Innovative Medicines France Huningue abril 11, 2025 Technicien(ne) de Laboratoire - Transfert ...

With new manufacturing capacity, Novartis will be able to produce 100% of its key medicines end-to-end in the US, a significant increase from current levels Increased R&D presence planned includes a ...